Frazier Life Sciences Management, L.P.
PALO ALTO, CA · CIK 1892134 · 13F filing filed 2023-05-15
SEC-registered investment adviser since 2021 · limited partnership
- Assets managed$7.0bn
- Staff64 · 47 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds8 (1 hedge) · $7.0bn gross assets
- Websitefrazierls.com
- Form ADV · 2026-03-31SEC adviser record
- Legal entityFrazier Life Sciences Management, L.P. (US)
- Kindhedge funds, private equity, venture
- Others nearbyPalo Alto, CA, San Diego, CA
As an employer
- Offices in1 country
- Private fundsventure capital 4, hedge 1, private equity 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| Palo Alto, CA (main office)United States | about 44 |
| San Diego, CAUnited States | 3 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$1.4bn
reported value
-14.1% vs Q4 2022
49positions
65.3%in top 10
8 new
7 added
4 reduced
3 sold out
vs Q4 2022
Holdings, Q1 2023
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| HILLEVAX INC COM | $161.7m11.71% | Added +23.1k |
| NEWAMSTERDAM PHARMA COMPANY NAMS | $125.6m9.09% | Unchanged |
| CHINOOK THERAPEUTICS INC ADRO | $100.6m7.28% | Unchanged |
| ARCUTIS BIOTHERAPEUTICS INC ARQT | $95.5m6.92% | Unchanged |
| MIRUM PHARMACEUTICALS INC MIRM | $92.7m6.71% | Unchanged |
| SYNDAX PHARMACEUTICALS INC SNDX | $78.3m5.67% | Unchanged |
| KRYSTAL BIOTECH INC KRYS | $75.7m5.48% | Reduced -54.3k |
| PHATHOM PHARMACEUTICALS INC PHAT | $60.0m4.35% | Unchanged |
| VERONA PHARMA PLC VRNA | $59.1m4.28% | Added +128.6k |
| VAXCYTE INC PCVX | $52.4m3.79% | Unchanged |
| RHYTHM PHARMACEUTICALS INC RYTM | $38.6m2.80% | Added +270.7k |
| KALVISTA PHARMACEUTICALS INC KALV | $25.5m1.84% | Unchanged |
| COGENT BIOSCIENCES INC COGT | $23.3m1.69% | Added +50.0k |
| ALPINE IMMUNE SCIENCES INC NVLS | $23.1m1.67% | Unchanged |
| TYRA BIOSCIENCES INC TYRA | $22.8m1.65% | Added +93.6k |
| CRINETICS PHARMACEUTICALS IN CRNX | $22.7m1.65% | Unchanged |
| TARSUS PHARMACEUTICALS INC TARS | $22.5m1.63% | Unchanged |
| THESEUS PHARMACEUTICALS INC COM | $20.0m1.45% | Added +850.0k |
| ANAPTYSBIO INC ANAB | $19.6m1.42% | Unchanged |
| BRIDGEBIO PHARMA INC BBIO | $19.4m1.41% | New |
| REVOLUTION MEDICINES INC RVMD | $18.5m1.34% | New |
| ENLIVEN THERAPEUTICS INC ELVN | $18.2m1.32% | New |
| ACADIA PHARMACEUTICALS INC ACAD | $16.1m1.17% | Unchanged |
| GRITSTONE BIO INC GRTS | $14.4m1.04% | Unchanged |
| MERUS N V MRUS | $13.7m0.99% | Unchanged |
| TREVI THERAPEUTICS INC TRVI | $12.3m0.89% | Unchanged |
| MACROGENICS INC MGNX | $12.2m0.88% | New |
| REPLIMUNE GROUP INC REPL | $12.1m0.88% | Reduced -244.8k |
| VECTIVBIO HLDG AG ORD SHS | $11.6m0.84% | Added +18.8k |
| CEREVEL THERAPEUTICS HLDNG I CERE | $9.6m0.69% | Unchanged |
| IMMUNOVANT INC IMVT | $9.1m0.66% | Unchanged |
| SUTRO BIOPHARMA INC COM | $8.2m0.59% | Unchanged |
| MORPHIC HLDG INC MORF | $8.1m0.58% | New |
| ARVINAS INC ARVN | $7.8m0.56% | Unchanged |
| AVIDITY BIOSCIENCES INC RNA | $7.7m0.56% | Unchanged |
| INTELLIA THERAPEUTICS INC NTLA | $7.6m0.55% | Unchanged |
| AUTOLUS THERAPEUTICS PLC AUTL | $6.9m0.50% | Unchanged |
| AEROVATE THERAPEUTICS INC COM | $6.8m0.49% | New |
| PROTHENA CORP PLC PRTA | $6.2m0.45% | Unchanged |
| ZYMEWORKS INC ZYME | $5.5m0.40% | Unchanged |
| SILENCE THERAPEUTICS PLC SLN | $5.5m0.40% | Unchanged |
| ALLAKOS INC ALLKG | $5.0m0.36% | Reduced -3.7m |
| BLUEBIRD BIO INC COM | $4.6m0.33% | Unchanged |
| EDGEWISE THERAPEUTICS INC EWTX | $4.6m0.33% | New |
| PASSAGE BIO INC COM | $3.6m0.26% | Unchanged |
| ADC THERAPEUTICS SA ADCT | $3.2m0.23% | New |
| ACLARIS THERAPEUTICS INC ACRS | $2.1m0.15% | Reduced -25.8k |
| NEWAMSTERDAM PHARMA COMPANY NAMSW | $920.6k0.07% | Unchanged |
| NABRIVA THERAPEUTICS PLC NBRVF | $29.7k0.00% | Unchanged |
Sold out since Q4 2022
| Security | Value then |
|---|---|
| IMAGO BIOSCIENCES INC | $143.3m4.0m shares |
| ESSA PHARMA INC EPI | $1.5m605.1k shares |
| APTINYX INC | $537.3k1.9m shares |